Stock Market Today: Nasdaq Notches Another High as COVID's Spread Worsens
An error in AstraZeneca's COVID-19 vaccine trial and persistent coronavirus troubles in the U.S. led investors to chase the old COVID trade Friday.
The broader markets closed the week with a passive partial session on Black Friday as setbacks in the fight against COVID challenged investors yet again to rethink their vigorous rotation into value stocks.
One worry: AstraZeneca's (AZN) admission that its scientists accidentally gave half-doses of its vaccine to one batch of volunteers – a mistake that could delay approval until more data can be gathered. Meanwhile, the U.S. tallied another 100,000 coronavirus cases on Thanksgiving and reported record hospitalizations (90,481) for the 17th consecutive day.
The Dow Jones Industrial Average finished up 0.1% to 29,910, while the Nasdaq Composite closed with a solid 0.9% gain to a record-high 12,205, led by Google parent Alphabet (GOOGL, +1.3%) and Netflix (NFLX, +1.3%).
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Nasdaq also enjoyed a bump from Tesla (TSLA, +2.1%), whose shares have continued their wild 2020 rally amid broader enthusiasm for EV stocks, given what should be an accommodative Joe Biden administration. Tesla is now the sixth-largest U.S. stock at $555 billion in market value by virtue of passing Warren Buffett's Berkshire Hathaway (BRK.B, -0.7%, $543 billion) today.
Other action in the stock market today:
- The S&P 500 edged 0.2% higher to 3,638.
- The Russell 2000 improved by 0.6% to finish at 1,855, eclipsing its all-time high set on Tuesday.
- U.S. crude oil futures declined 0.9% to settle at $45.32 per barrel.
- Gold futures dipped heavily, sagging 2.4% to $1,788.10 per ounce.
Start Thinking About Your 401(k)
We're getting close to that time of year when even the least-active investors take a peek at their 401(k)s. For savvier Closing Bell readers, it's time to take a long, hard look at every investment in your 401(k) to make sure it's giving you the most bang for your buck.
We continue our series on 401(k) mutual-fund picks – which so far has included Vanguard, Fidelity and T. Rowe Price – with a look at the most popular 401(k) offerings from American Funds, whose managers are keenly aware of how much value they're adding.
Why? Because the culture of Capital Group, which manages the American Funds, includes having some skin in the game. As Kiplinger's senior associate editor Nellie Huang points out, "Many American Funds have at least one manager with more than $1 million of his or her own money invested in the portfolio."
Read on as we break down 14 American Funds that are commonly found in 401(k) plans, rating each one a Buy, Hold or Sell.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Kyle Woodley is the Editor-in-Chief of WealthUp, a site dedicated to improving the personal finances and financial literacy of people of all ages. He also writes the weekly The Weekend Tea newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.
Kyle was previously the Senior Investing Editor for Kiplinger.com, and the Managing Editor for InvestorPlace.com before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism.
You can check out his thoughts on the markets (and more) at @KyleWoodley.
-
Tax Season 2026 Is Here: 8 Big Tax Changes to Know Before You FileTax Tips Due to several major tax rule changes, your 2025 return might feel unfamiliar even if your income looks the same.
-
The New Rules of RetirementPopular guidelines about how to save, invest and spend need to be updated and personalized to ensure you'll never run out of money.
-
Humanoid Robots Are About to be Put to the TestThe Kiplinger Letter Robot makers are in a full-on sprint to take over factories, warehouses and homes, but lofty visions of rapid adoption are outpacing the technology’s reality.
-
Nasdaq Leads Ahead of Big Tech Earnings: Stock Market TodayPresident Donald Trump is making markets move based on personal and political as well as financial and economic priorities.
-
11 Stock Picks Beyond the Magnificent 7With my Mag-7-Plus strategy, you can own the mega caps individually or in ETFs and add in some smaller tech stocks to benefit from AI and other innovations.
-
Nasdaq Adds 211 Points as Greenland Tensions Ease: Stock Market TodayWall Street continues to cheer easing geopolitical tensions and President Trump's assurances that there will be no new tariffs on Europe.
-
Dow Soars 588 Points as Trump Retreats: Stock Market TodayAnother up and down day ends on high notes for investors, traders, speculators and Greenland.
-
If You'd Put $1,000 Into UPS Stock 20 Years Ago, Here's What You'd Have TodayUnited Parcel Service stock has been a massive long-term laggard.
-
Nasdaq Takes a Hit as the Tech Trade Falters: Stock Market TodayThe Dow Jones Industrial Average outperformed on strength in cyclical stocks.
-
Stocks Struggle for Gains to Start 2026: Stock Market TodayIt's not quite the end of the world as we know it, but Warren Buffett is no longer the CEO of Berkshire Hathaway.
-
If You'd Put $1,000 Into Lowe's Stock 20 Years Ago, Here's What You'd Have TodayLowe's stock has delivered disappointing returns recently, but it's been a great holding for truly patient investors.
